Cerebellar and posterior fossa malformations in patients with autism‐associated chromosome 22q13 terminal deletion

The 22q13.3 deletion causes a neurodevelopmental syndrome, also known as Phelan‐McDermid syndrome (MIM #606232), characterized by developmental delay and severe delay or absence of expressive speech. Two patients with hemizygous chromosome 22q13.3 telomeric deletion were referred to us when brain‐imaging studies revealed cerebellar vermis hypoplasia (CBVH). To determine whether developmental abnormalities of the cerebellum are a consistent feature of the 22q13.3 deletion syndrome, we examined brain‐imaging studies for 10 unrelated subjects with 22q13 terminal deletion. In seven cases where the availability of DNA and array technology allowed, we mapped deletion boundaries using comparative intensity analysis with single nucleotide polymorphism (SNP) microarrays. Approximate deletion boundaries for three additional cases were derived from clinical or published molecular data. We also examined brain‐imaging studies for a patient with an intragenic SHANK3 mutation. We report the first brain‐imaging data showing that some patients with 22q13 deletions have severe posterior CBVH, and one individual with a SHANK3 mutation has a normal cerebellum. This genotype–phenotype study suggests that the 22q13 deletion phenotype includes abnormal posterior fossa structures that are unlikely to be attributed to SHANK3 disruption. Other genes in the region, including PLXNB2 and MAPK8IP2, display brain expression patterns and mouse mutant phenotypes critical for proper cerebellar development. Future studies of these genes may elucidate their relationship to 22q13.3 deletion phenotypes. © 2012 Wiley Periodicals, Inc.

[1]  Luigi Boccuto,et al.  Association between deletion size and important phenotypes expands the genomic region of interest in Phelan–McDermid syndrome (22q13 deletion syndrome) , 2011, Journal of Medical Genetics.

[2]  A. Beaudet,et al.  Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. , 2011, Human molecular genetics.

[3]  M. Fichera,et al.  Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome , 2011, PLoS genetics.

[4]  D. Linden,et al.  RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism , 2011, Cell.

[5]  G. Feng,et al.  Shank3 mutant mice display autistic-like behaviours and striatal dysfunction , 2011, Nature.

[6]  H. Zoghbi,et al.  In vivo Atoh1 targetome reveals how a proneural transcription factor regulates cerebellar development , 2011, Proceedings of the National Academy of Sciences.

[7]  S. Mundlos,et al.  Copy-number variations involving the IHH locus are associated with syndactyly and craniosynostosis. , 2011, American journal of human genetics.

[8]  Mark J. Harris,et al.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication , 2010, Molecular autism.

[9]  Egidio D'Angelo,et al.  Behavioral and Cerebellar Transmission Deficits in Mice Lacking the Autism-Linked Gene Islet Brain-2 , 2010, The Journal of Neuroscience.

[10]  Z. Ou,et al.  Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH , 2010 .

[11]  Allan R. Jones,et al.  The Allen Brain Atlas: 5 years and beyond , 2009, Nature Reviews Neuroscience.

[12]  A. Toutain,et al.  Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. , 2009, European journal of medical genetics.

[13]  A. Munnich,et al.  Neurobehavioral Profile and Brain Imaging Study of the 22q13.3 Deletion Syndrome in Childhood , 2008, Pediatrics.

[14]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[15]  Christian R Marshall,et al.  Contribution of SHANK3 mutations to autism spectrum disorder. , 2007, American journal of human genetics.

[16]  Chiara Gagliardi,et al.  Disorders of cognitive and affective development in cerebellar malformations. , 2007, Brain : a journal of neurology.

[17]  P. Rakic,et al.  Requirement of JIP scaffold proteins for NMDA-mediated signal transduction. , 2007, Genes & development.

[18]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[19]  C. Sotelo,et al.  Plexin-B2 Controls the Development of Cerebellar Granule Cells , 2007, The Journal of Neuroscience.

[20]  E. Courchesne,et al.  MRI neuroanatomy in young girls with autism: a preliminary study. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  Thomas Bourgeron,et al.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.

[22]  G. Allen Cerebellar contributions to autism spectrum disorders , 2006, Clinical Neuroscience Research.

[23]  Christoph Schmitz,et al.  The Developmental Neurobiology of Autism Spectrum Disorder , 2006, The Journal of Neuroscience.

[24]  Eckart D Gundelfinger,et al.  An Architectural Framework That May Lie at the Core of the Postsynaptic Density , 2006, Science.

[25]  J. Opitz,et al.  Two brothers with 22q13 deletion syndrome and features suggestive of the Clark–Baraitser syndrome , 2005, Clinical dysmorphology.

[26]  T. Kemper,et al.  Neuroanatomic observations of the brain in autism: a review and future directions , 2005, International Journal of Developmental Neuroscience.

[27]  C. Lundsteen,et al.  Further delineation of the 22q13 deletion syndrome , 2005, Clinical dysmorphology.

[28]  H. Sariola,et al.  The expression of plexins during mouse embryogenesis. , 2005, Gene expression patterns : GEP.

[29]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[30]  J. Schmahmann,et al.  Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[31]  J. Graham,et al.  22q13 Deletion Syndrome: An Update and Review for the Primary Pediatrician , 2004, Clinical pediatrics.

[32]  H. McDermid,et al.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.

[33]  Eric Courchesne,et al.  Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. , 2003, The American journal of psychiatry.

[34]  R. Borgatti,et al.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome. , 2001, American journal of human genetics.

[35]  K. Doheny,et al.  Cryptic terminal rearrangement of chromosome 22q13.32 detected by FISH in two unrelated patients. , 1997, Journal of medical genetics.

[36]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.